Journal Report

European urology

Download PDF
Journal Information
Journal Title
European urology
Publisher
ISSN
0302-2838
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Re: Aboubacar Kaba, Pratik Kanabur, Jeremie Calais, et al. Performance of [89 Zr]girentuximab PET/CT in Predicting the Presence of Any Renal Malignancy: A Reanalysis of the ZIRCON Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.003
Alireza Ghoreifi, Michael Daneshvar
2026-10 Vol. 90 Issue 4 Pages e82-e83
Reply to Vallée M, Stangl FP, Wagenlehner F et al’s Letter to the Editor re: Tikkinen KAO, Najafabadi BT, Hajebrahimi S, et al. A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections After Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial. Eur Urol 2025;88(6):543–51
Kari A.O. Tikkinen, Farhad Tondroanamag, Sameer Parpia et al.
2026-10 Vol. 90 Issue 4 Pages e86-e87
Validation of a Computational Histology Artificial Intelligence–based Biomarker for BCG Treatment in Non–muscle-invasive Bladder Cancer in the ANZUP 1301 Randomized Phase 3 Trial
Dickon Hayne, Lisa Spalding, Cynthia Hawks et al.
2026-10
Re: Microultrasonography-guided Versus MRI-guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial
Rossano Girometti, Francesco Giganti
2026-10
Re: Kari A. O. Tikkinen, Maura Marcucci, Alex L. E. Halme, et al. Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-controlled POISE-3 Trial. Eur Urol 2026;90:140–9
Kristoffer Mazanti Cold, Frederik Ferløv Thomsen, Jakob Stensballe et al.
2026-10
When the Platform Owns the Procedure: Intellectual Property Rights and Robotic Surgery
Benjamin Davies, David Canes, Quoc-Dien Trinh et al.
2026-10 Vol. 90 Issue 4 Pages e84-e86
Re: Emanuele Messina, Antonella Borrelli, Alessandro Sciarra, et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2025;89:246–57
Stefano De Luca, Luca Ferrando, Francesco Porpiglia
2026-10 Vol. 90 Issue 4 Pages e91
Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial
Sian Cooper, Jaymini Patel, Caroline Moore et al.
2026-10 Vol. 90 Issue 4 Pages 321-327
Reply to Riccardo Lombardo’s Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020
Bi-Ming He, Hai-Feng Wang
2026-10
Re: Sobia Khan, Nathan Papa, Andrew Kneebone, et al. Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium [68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol 2026;89:512–20
Elif Hindié, Aurélien Callaud, Clément Morgat
2026-10
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 30, 2026 07:43